27 related articles for article (PubMed ID: 16112023)
1. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
Ohno Y; Kitamura H; Takahashi N; Ohtake J; Kaneumi S; Sumida K; Homma S; Kawamura H; Minagawa N; Shibasaki S; Taketomi A
Cancer Immunol Immunother; 2016 Feb; 65(2):193-204. PubMed ID: 26759006
[TBL] [Abstract][Full Text] [Related]
2. Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model.
Cui Z; Qiu F
Cancer Immunol Immunother; 2006 Oct; 55(10):1267-79. PubMed ID: 16362407
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells are dysfunctional in patients with operable breast cancer.
Satthaporn S; Robins A; Vassanasiri W; El-Sheemy M; Jibril JA; Clark D; Valerio D; Eremin O
Cancer Immunol Immunother; 2004 Jun; 53(6):510-8. PubMed ID: 14740176
[TBL] [Abstract][Full Text] [Related]
4. A novel monoclonal antibody against squamous cell carcinoma.
Inoue M; Nakanishi K; Sasagawa T; Tanizawa O; Inoue H; Hakura A
Jpn J Cancer Res; 1990 Feb; 81(2):176-82. PubMed ID: 1692016
[TBL] [Abstract][Full Text] [Related]
5. Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods.
Tîrziu A; Avram S; Madă L; Crișan-Vida M; Popovici C; Popovici D; Faur C; Duda-Seiman C; Păunescu V; Vernic C
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513985
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins.
Panahi HA; Bolhassani A; Javadi G; Noormohammadi Z
PLoS One; 2018; 13(10):e0205933. PubMed ID: 30356257
[TBL] [Abstract][Full Text] [Related]
7. T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.
Woodham AW; Yan L; Skeate JG; van der Veen D; Brand HH; Wong MK; Da Silva DM; Kast WM
Papillomavirus Res; 2016 Dec; 2():21-30. PubMed ID: 27182559
[TBL] [Abstract][Full Text] [Related]
8. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination.
Yang B; Yang A; Peng S; Pang X; Roden RB; Wu TC; Hung CF
Cell Biosci; 2015; 5():35. PubMed ID: 26113972
[TBL] [Abstract][Full Text] [Related]
9. Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.
Lacasse P; Denis J; Lapointe R; Leclerc D; Lamarre A
J Virol; 2008 Jan; 82(2):785-94. PubMed ID: 17989184
[TBL] [Abstract][Full Text] [Related]
10. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
[TBL] [Abstract][Full Text] [Related]
11. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
[TBL] [Abstract][Full Text] [Related]
12. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.
Rudolf MP; Fausch SC; Da Silva DM; Kast WM
J Immunol; 2001 May; 166(10):5917-24. PubMed ID: 11342606
[TBL] [Abstract][Full Text] [Related]
13. Modulation of antigen presenting cell functions during chronic HPV infection.
Bashaw AA; Leggatt GR; Chandra J; Tuong ZK; Frazer IH
Papillomavirus Res; 2017 Dec; 4():58-65. PubMed ID: 29179871
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro.
Warrino DE; Olson WC; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Da Silva DM; Kast WM; Storkus WJ
Hum Immunol; 2005 Jul; 66(7):762-72. PubMed ID: 16112023
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
